Head and Neck Atopic Dermatitis: Therapeutic Response After Switching to Upadacitinib in Moderate-to-Severe Atopic Dermatitis Patients Who Had Inadequate Response to Dupilumab. (2026). SKIN The Journal of Cutaneous Medicine, 10(2), s740. https://doi.org/10.25251/ztj3rn69